Diversity Panel Discusses Asian Experience in Cancer Research Hosted by Society for Immunotherapy of Cancer and Others
Share Article
The Society for Immunotherapy of Cancer (SITC), in collaboration with the Chinese American Hematologist and Oncologist Network (CAHON) and the Indo-American Cancer Association (IACA), is pleased to release an important diversity panel discussion of society leaders sharing their experience as Asians working in the cancer research field.
Barriers to Asians and Pacific Islanders in Science and Medicine Diversity Panel Logo
This diversity panel features a timely and intimate discussion of the interactions my fellow Asian colleagues have experienced in the laboratory and the clinic, stories that are unfortunately all too common,” said SITC President Patrick Hwu, MD.
TORONTO An 89-year-old man has died after he was pinned between two vehicles moments after walking out of a downtown hospital on Wednesday. The senior was walking out of the Murray Street entrance of the Princess Margaret Cancer centre, located near University Avenue and College Street, at around 2:30 p.m. when he was struck. According to police, the man stepped between two stopped cars that were in the patient pick-up and drop-off driveway of the centre and as he did so, a 2012 Chevrolet Cruz being driven by a 65-year-old man moved forward. The man was pinned between the Cruz and and a stationary 2017 Toyota Sienna minivan.
BARRIE, ONT. You could score a restful getaway at a cottage to call your own and help cure cancer at the same time. There are three waterfront homes up for grabs in the Princess Margaret Cottage Lottery this summer; in Georgian Bay, Muskoka and Kawartha. Each home is priced at more than $1-million and comes a $50,000 cash prize. Ticket packs start as low as $25, with proceeds helping to fund cancer research. It is really these trials that will fuel novel new therapies that will not only benefit cancer patients in Ontario and Canada, but really cancer patients around the world, says Ramona Oss with the Princess Margaret Cancer Foundation.
E-Mail
IMAGE: Senior author and Princess Margaret Scientist Dr. Marianne Koritzinsky s research reveals the potential of targeted therapies to exploit unique metabolic features of pancreatic cancer cells. view more
Credit: Visual Services, UHN
(Toronto, Friday, May 7, 2021) Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to kill them.
Led by Princess Margaret Cancer Centre (PM) Scientist Dr. Marianne Koritzinsky, researchers showed that about half of patient-derived pancreatic cancer cell lines are highly dependent or addicted to the protein peroxiredoxin 4 (PRDX4), as a result of the altered metabolic state of the cancer cell.